Monday, September 21, 2020
Home Life Style Health & Fitness Chinese Scientists Develop Combined Tumor-Killing Therapy

Chinese Scientists Develop Combined Tumor-Killing Therapy

The Chinese Academy of Sciences and Fudan University developed a common immune checkpoint inhibitor in a nanoparticle formulation

Chinese scientists developed a combined tumor-killing therapy that can be activated specifically at tumor sites in mouse models of cancer, which is more effective than previous similar therapies.

The study published on Friday in the journal Science Immunology described the new cancer immunotherapy that can prevent the immune system from becoming tolerant of tumors, which occurs in 30 per cent of all cancer patients, the Xinhua news agency reported.

A team led by Wang Dangge from Shanghai Institute of Materia Medica under the Chinese Academy of Sciences and Fudan University developed a common immune checkpoint inhibitor in a nanoparticle formulation, which is highly tumor-specific.

The checkpoint inhibitor is a kind of increasingly popular anti-tumor drug. It can block proteins that keep immune T cells from killing cancer. But the checkpoint inhibitor used to target those immune system-suppressing proteins like PD-1 and PD-L1 often fails to reach deep-seated or metastatic tumors.

Chinese, Scientists, Tumor
Chinese scientists developed a combined tumor-killing therapy that can be activated specifically at tumor sites in mouse models of cancer, Pixabay

Wang’s team combined the nanoparticles carrying PD-L1-targeting antibodies with a light-activated molecule. The molecule called photosensitiser can produce tumor-killing reactive oxygen species after encountering a protein abundant in tumors, according to the study.

In mouse models, a local near-infrared radiation that activated the photosensitiser, along with the administration of antibodies-carrying nanoparticles, promoted the infiltration of cancer cell-killing T cells into the tumor site and made the tumors more sensitive to the checkpoint blockade.

Also Read- Musk’s Neuralink Developing Ultra-High Bandwidth Brain-Machine Interfaces

This combination also helped the nanoparticles effectively suppress tumor growth and metastasis to the lung and lymph nodes, resulting in approximately 80 per cent mouse survival over 70 days, compared to complete mouse death in 45 days in the group treated with only PD-L1 antibodies, according to the study. (IANS)

STAY CONNECTED

19,146FansLike
362FollowersFollow
1,775FollowersFollow

Most Popular

This Breast Cancer Drug May Help Prostate Cancer Patients

A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer, showed results of a major...

Let’s Celebrate World Alzheimer’s Day!

World Alzheimer's Day is observed every year on September 21. The Alzheimer's disease is seen in people especially after 65 years of age where...

Breathing: One of the Most Common Ways by Which Coronavirus is Spread

As the United States nears 200,000 deaths from COVID-19, the Centers for Disease Control and Prevention updated its guidelines to add breathing to the...

Bevli Has An Infectious Enthusiasm Towards Plogging

When eco-fitness enthusiast Ripu Daman Bevli started to pick trash off the streets alongside his jogging regimen, a few years ago, people would curiously...

The Mode Of Imparting Education Leads Educators To Fend For Themselves: Innovator Krishna

Gaps in universality of the mode of imparting education often leads educators to fend for themselves and figure out things on their own, says...

Only 4% Patients Able to Get a Covid-19 ICU Bed Through Routine Process: Survey

Only four per cent patients were able to get a Covid-19 ICU bed through the routine process, while 78 per cent had to use...

Rheumatoid Arthritis Patients May be at 23% Increased Risk of Developing Diabetes

People suffering from rheumatoid arthritis may be at 23 per cent increased risk of developing Type-2 diabetes, says a new study. The study, presented at...

College Students With Disabilities at Higher Risk of Drug Abuse: Study

College students with physical and cognitive disabilities have a higher prevalence of drug use disorder, than their non-disabled peers, according to a study by...

Recent Comments